SHARE THE SCIENCE welcomes Dr. Joanne Kurtzberg for an exclusive presentation at the AABB Conference.UPDATE: This presentation was given live at the AABB conference on October 26th. If you are interested in viewing a recording of this presentation, please send an email with your request to email@example.com . All requests will be reviewed by Dr. Kurtzberg prior to release. Thank you.
Save the Cord Foundation and Mediware are pleased to announce this exclusive opportunity for those in the medical community to learn about the latest research in the cord blood industry from Dr. Joanne Kurtzberg who is one of the most well-known and respected doctors in this field. Dr. Kurtzberg will be presenting “GAME CHANGERS: Using Cord Blood to Help the Brain.” Director of Carolinas Cord Blood Bank and CSO of Robertson Clinical and Translational Cell Therapy Program, Dr. Kurtzberg will discuss the evolution of cord blood banking and transplantation, new clinical applications for cord blood therapies and using cord blood to help the brain.
ANAHEIM CONVENTION CENTER Room 207A/B| ANAHEIM, CA | MONDAY, OCTOBER 26TH, 2015| 7:00 – 8:15 AM PACIFIC TIME
This presentation will be given live at the AABB Annual Conference in Anaheim, CA.
Attendance will be limited.
Please register early to secure your place.
Summary of the presentation:
Cord blood contains stem and progenitor cells of hematopoietic lineage. It has been banked and successfully used as a source of cells for hematopoietic reconstitution in hematopoietic stem cell transplantation (HSCT) from related and unrelated donors for more than two decades. Cord blood cells are immunologically tolerant and able to be transplanted without full HLA matching, providing increased access to transplantation for patients who lack fully matched related or unrelated donors.
HSCT, using unrelated donor umbilical cord blood, has been used to treat children with selective inborn errors of metabolism since 1995. Studies in these children have shown that cord blood cells, administered intravenously, home to and engraft in the brain. These observations led us to hypothesize that cord blood cells might also have efficacy treating patients with acquired brain injuries. Preclinical work in animal and in vitro models demonstrated that cord blood cells could decrease inflammation, phagocytize debris, promote neurogenesis, promote oligodendrocyte proliferation, induce myelination and protect neurons from hypoxic injury. Clinical studies to date have been performed to demonstrate the safety of intravenous infusions of autologous cord blood, and efficacy studies are underway in babies with hypoxic ischemic encephalopathy and in young children with cerebral palsy, congenital hydrocephalus and autism. With encouraging early results and the knowledge that many patients will not have access to autologous cord blood, allogeneic studies in adults with ischemic stroke was recently initiated. The long-term goal of these studies is to develop a variety of allogeneic cord blood products that can help patients with acquired and genetic brain injuries.
- The history and evolution of cord blood banking and transplantation;
- The differences between public and family banks;
- About quality measures of cord blood units; and
- About new clinical applications for cord blood therapies.
And don’t forget. . .
Join us for a much anticipated free webinar with Dr. Susana Gomez on October 15th, 2015 from 11am CST from Anthony Nolan Cell Therapy Center in the UK. Dr. Susana Gomez, will speak about the important role that cord blood banks play in stem cell transplantation, the quality assays and standards that must be met, and the importance of the validations and qualification processes.
Since 2008, Dr. Susana G. Gomez has served as head of cord blood bank at Anthony Nolan Cell Therapy Centre (ANCTC), which is a FACT NetCord accredited facility in Nottingham (UK). She is also the designated individual (DI) for the Human Tissue Authority (HTA) license, and she has a Visiting Fellow in College of Science in Nottingham Trent University.
Dr. Gomez, who has a Ph.D. in heamatotoxicity, started her career at the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER). She has been involved in clinical trials and has extensive experience in mesenchymal stem cell research as well as GMP compliance.
Join us as Dr. Gomez discusses quality in cord blood banking and let’s learn how the industry can continue to achieve amazing results by maintaining a strict standards throughout.
Save the Cord Foundation and Mediware wish to thank both Dr. Kurtzberg and Dr. Gomez for participating in our Share the Science series.